We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
National Services Scotland (NSS) has requested NHS Digital to collect and analyse Hospital Electronic Prescribing and Medicines Administration (HEPMA) data from four NHS Health Boards in Scotland for COVID-19 purposes. The data will be disseminated back to NSS to support the NHS in Scotland and Scottish Government’s response to the COVID-19 pandemic.
The data collected will include:
- what medicines have been prescribed to patients in hospital settings
- how and when the medicine was taken by the patient (administration)
- the reasons for prescribing if this is available (known as indications)
- the patient’s CHI number
- what stage of the patient’s journey through the hospital the data relates to (where available).
Scope of the collection
This Notice is served on:
- the four NHS Health Boards in Scotland using WellSky HEPMA systems which have agreed to participate in the collection.
Period of the collection
Specific collection dates will be agreed with the individual Health Boards.
Initially the collection will take data from 1 January 2020, to be followed by a further historic collection of data from 1 January 2019. Once this is completed, submissions will start on a daily basis.
A formal review will take place with NHSX and Public Health Scotland before 30 September 2020 when the first six monthly review under the COVID-19 National Services Scotland Non-Mandatory Request 2020 is due to take place.